Legato Capital Management LLC Viking Therapeutics, Inc. Transaction History
Legato Capital Management LLC
- $713 Million
- Q2 2024
A detailed history of Legato Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Legato Capital Management LLC holds 4,540 shares of VKTX stock, worth $245,750. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,540
Previous 14,702
69.12%
Holding current value
$245,750
Previous $1.21 Million
80.08%
% of portfolio
0.03%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$547 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$326 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$277 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$122 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$101 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.15B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...